Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05597865
Other study ID # 1R21AA030225-01
Secondary ID 1R21AA030225-01
Status Recruiting
Phase N/A
First received
Last updated
Start date October 12, 2023
Est. completion date May 2024

Study information

Verified date December 2023
Source Washington University School of Medicine
Contact Rachel Brathwaite, PhD
Phone 3149351775
Email rachel.brathwaite@yahoo.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The proposed study will test the impact of an economic empowerment intervention on reducing alcohol and drug use (ADU) among adolescents and youth living with HIV (AYLHIV) in poverty-impacted communities in Uganda. It focuses on improving understanding of multi-level context- specific risk and protective factors for ADU among AYLHIV.


Description:

Adolescent alcohol and drug use (ADU) is a significant public health challenge in sub-Saharan Africa (SSA). About 41.6% of adolescents in SSA reported using at least one psychoactive agent, with alcohol being the most commonly used drug. Uganda, one of the poorest countries in SSA, has the second highest rate of per capita alcohol consumption in SSA (15.1 liters of pure alcohol vs regional average of 6.2 liters of pure alcohol) and one third of Ugandan adolescents have used alcohol in their lifetime, 22.5 million are current drinkers, and over 50% engage in heavy episodic drinking. These estimates reach even greater magnitudes in the country's fishing villages - a key vulnerable population- where ADU is normative. A few studies have assessed ADU among AYLHIV, yet AYLHIV are at higher risk for ADU, and ADU impedes adherence to antiretroviral therapy (ART) retention in care, and viral suppression. Several studies have examined the risk and resilience factors for ADU but few interventions targeting ADU have been tested in SSA. . The majority of ADU interventions have been implemented in school settings, which may exclude adolescents in fishing communities that have high rates of school dropout. Moreover, none has targeted risk factors such as poverty and mental health, which are rampant among AYLHIV and their families, undermine AYLHIV's coping skills and resources, and have been associated with increased risk for ADU among adolescents. Economic empowerment (EE) interventions have the potential to prevent ADU among AYLHIV by reducing poverty and its associated mental health impacts, and also bolstering AYLHIV and their families' resources to overcome the challenges associated with HIV. Given the lack of evidence-based culturally tailored interventions to prevent ADU in AYLHIV in low-income settings such as Uganda, this study proposes to: Aim 1a. Examine the prevalence and consequences of ADU in a sample of 200 AYLHIV (ages 18-24) seen at six (6) HIV clinics located in the fishing communities of southwestern Uganda. ADU will be measured using self-report and biological data (i.e. urine). Aim 1b. Using a mixed methods approach, identify the multi-level (individual, interpersonal, community and structural) factors associated with ADU among AYLHIV. Aim 2: Using a subset of the sample, explore the feasibility and short-term effects of a EE intervention on ADU among AYLHIV. Our intervention focuses on older adolescents and young adults in a high-risk environment (i.e. fishing communities) to elucidate the contextually relevant risk and resilience factors for ADU among AYLHIV undergoing social transitions. Additionally we innovatively target the most commonly occurring risk and resilience factors for ADU (i.e. poverty and mental health problems) through the EE that includes provision of youth development savings accounts, financial literacy sessions and ADU risk reduction sessions.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date May 2024
Est. primary completion date May 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 24 Years
Eligibility Inclusion Criteria for AYLHIV: 1. male or female AYLHIV aged 15-24 years; 2. medically diagnosed with HIV and aware of their HIV status; 3. enrolled in care at one of the selected HIV clinics. 4. positive self-report or urine test for alcohol or drug use Exclusion Criteria: 1. any AYLHIV with negative urine alcohol or drug use test and negative self-report for alcohol and drug use 2. anyone with a significant cognitive impairment that interferes with their understanding of the informed consent process, or is unable/unwilling to consent.

Study Design


Intervention

Behavioral:
Economic Empowerment Intervention
Economic Empowerment Intervention comprising Financial Literacy Sessions and Youth Development Accounts
Alcohol and Drug Use Risk Reduction Sessions
All participants in the control and treatment arm will receive Alcohol and Drug Use Risk Reduction sessions tailored for Adolescents and Youths Living with HIV.

Locations

Country Name City State
Uganda International Center for Child Health and Development Field Office Masaka

Sponsors (2)

Lead Sponsor Collaborator
Washington University School of Medicine National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Country where clinical trial is conducted

Uganda, 

Outcome

Type Measure Description Time frame Safety issue
Primary Feasibility of the intervention Proportion of participants enrolled Proportion of participants refused Willingness of local partners to assist with recruitment Reasons for refusal or ineligibility Reasons for enrolment in intervention Change from Baseline to 6 months
Primary Acceptability of the intervention Retention and follow-up rates Proportion that adhered to study study procedures, intervention attendance and engagement Level of safety of the procedures in the intervention How the intervention fits with the daily life activities of study participants Where the intervention involves a reasonable amount of time, or it creates a burden for participants Extent to which intervention is acceptable and appealing to study participants Change from Baseline to 6 months
Secondary Alcohol/drug expectancies Alcohol expectancy scale Change from Baseline to 6 months
Secondary Change in Frequency and quantity of substance use SUBSTANCE USE assessed using NIDA-Modified ASSIST Urine tests for alcohol and drug use Change from Baseline to 6 months
Secondary Change in anti-retroviral treatment adherence Self-reported adherence Change from Baseline to 6 months
Secondary Change in Optimism Optimism scale Change from baseline to 6 months
Secondary Change in Hopelessness Beck's Hopelessness Scale Change from baseline to 6 months
Secondary Change in Depressive symptoms Center For Epidemiologic Studies Depression Scale Change from baseline to 6 months
Secondary Change in Self-efficacy in HIV treatment adherence Self-efficacy in HIV treatment adherence scale Change from baseline to 6 months
Secondary Change in Savings We will utilize bank statements and financial diaries to monitor savings Change from baseline to 6 months
Secondary Change in Self-concept TENNESSEE SELF-CONCEPT SCALE Change from baseline to 6 months
Secondary Change in PERECEIVED STRESS PERECEIVED STRESS SCALE Change from baseline to 6 months
Secondary Change in LONELINESS UCLA LONELINESS SCALE Change from baseline to 6 months
Secondary Change in Sexual risk-taking self-reported questions on sexual risk-taking Change from baseline to 6 months
See also
  Status Clinical Trial Phase
Completed NCT03413696 - Effects of Health Literacy and HCV Knowledge on HCV Treatment Willingness in HIV-coinfected Patients
Completed NCT03215901 - Life Plans Intervention Study N/A
Completed NCT03289676 - Storytelling Narrative Communication Intervention for Smoking Cessation in Women Living With HIV Phase 1
Completed NCT03268551 - MEMO-Medical Marijuana and Opioids Study
Active, not recruiting NCT04064567 - Linking High-Risk Jail Detainees to HIV Pre-Exposure Prophylaxis: PrEP-LINK N/A
Completed NCT04013295 - Prize-linked Savings Initiatives for Promoting Better Health and Economic Outcomes in Kenya N/A
Recruiting NCT04405700 - Measuring Adverse Pregnancy and Newborn Congenital Outcomes
Recruiting NCT03984136 - HIV Results Exchange Mechanism on Promoting HIV Testing Among MSM N/A
Completed NCT02928900 - Patient Actor Training to Improve HIV Services for Adolescents in Kenya N/A
Recruiting NCT03268109 - COGnitive ImpairmenT in Older HIV-infected Patients ≥ 65 Years Old
Completed NCT02797262 - Measuring and Monitoring Adherence to ART With Pill Ingestible Sensor System N/A
Completed NCT02376582 - Safety and Immunogenicity Study of a DNA Vaccine Combined With Protein Vaccine Against HIV/AIDS Phase 1
Completed NCT01957865 - Real-Time Antiretroviral Therapy Adherence Intervention in Uganda N/A
Completed NCT01616940 - Minority AIDS Initiative Retention and Re-Engagement Project N/A
Terminated NCT01443923 - Boceprevir Drug Combination for Hepatitis C Treatment in People With and Without HIV Phase 4
Completed NCT01910714 - Adapting and Evaluating an EBI to Prevent HIV/AIDS Risk Among Apache Youth N/A
Completed NCT01084421 - A Computer-Based Parent/Adolescent HIV Communication Intervention for Latinos N/A
Completed NCT01596322 - International HIV Antiretroviral Adherence, Resistance and Survival N/A
Completed NCT03643705 - A Nurse-led Intervention to Extend the HIV Treatment Cascade for Cardiovascular Disease Prevention N/A
Completed NCT03923231 - Pharmacokinetics of Atazanavir in Special Populations